Mitchell Stephen Ray

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 30% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Mitchell Stephen Ray's trades of Vanda Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
95.58
Quantity 50,550
Value US$3,471,231
Transaction date
Proposed sale
Price
5.40
Quantity 5,000
Value US$27,000
Transaction date
Proposed sale
Price
6.05
Quantity 6,500
Value US$39,349
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-16 2025-06-13
S Sale
38,851 +43.5%
48.32
US$2,414,231 		38,851 +43.5% 48.32 US$2,414,231
2025-06-13 2025-06-13
PrS Proposed sale
50,550
95.58
US$3,471,231 		50,550 95.58 US$3,471,231
2024-11-18 2024-11-14
S Sale
72,041 -1.2%
322.61
US$4,272,116 		72,041 -1.2% 322.61 US$4,272,116
2024-11-14 2024-11-14
PrS Proposed sale
5,000
5.40
US$27,000 		5,000 5.40 US$27,000
2023-08-11 2023-08-10
S Sale
6,500 -18.1%
6.05
US$39,349 		6,500 -18.1% 6.05 US$39,349
2023-08-10 2023-08-10
PrS Proposed sale
6,500
6.05
US$39,349 		6,500 6.05 US$39,349
2022-06-14 2022-06-13
S Sale
2,700 -29.3%
9.48
US$25,593 		2,700 -29.3% 9.48 US$25,593
2021-09-13 2021-09-09
S Sale
19,109 -67.5%
16.74
US$319,976 		19,109 -67.5% 16.74 US$319,976
2021-06-17 2021-06-15
S Sale
5,000 -35.2%
19.42
US$97,122 		5,000 -35.2% 19.42 US$97,122